Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts -- Build-out of customer-facing team on track for this quarter OLINVYK comprehensive product dossier / health economic model now available to facilitate formulary reviews -- CHESTERBROOK, Pa.,...

Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting -- Live presentation highlighting TRV027 as a potential treatment for COVID-19 acute respiratory distress syndrome (ARDS) / abnormal clotting Posters on OLINVYK benefit-risk profile and TRV250 Phase...

Trevena, Inc. to Present at September Virtual Investor Conferences - H.C. Wainwright: 22nd Annual Global Investment Conference -September 14th - Cantor Fitzgerald Virtual Global Healthcare Conference - September 17th -Oppenheimer Fall Healthcare Life Sciences...